Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol/dydrogesterone vs placebo for vasomotor symptoms in postmenopausal women
CTR20160689Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of estradiol + dydrogesterone in Hypoestrogenemia, vasomotor symptoms, sponsored by Abbott Laboratories. Started Oct 2016; status: completed.
02
Drugs
estradiol + dydrogesterone
03
Conditions
Hypoestrogenemiavasomotor symptoms
Beyond the preview
Go deeper on CTR20160689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160689.